long-acting erythropoietin (Harbin Pharmaceutical Group Bioengineering)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelong-acting erythropoietin (Harbin Pharmaceutical Group Bioengineering)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHarbin Pharmaceutical Group Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarbin Pharmaceutical Group Biological Engineering Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A